✦ LIBER ✦

Overexpression of erbB2/neu oncoprotein and Fas ligand death signals in breast cancer

✍ Scribed by F.M. Venanzi; R. Coppari; A. Smorlesi; E. Ripani; A. Concetti; A. Amici

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nuclear and flow cytometric characterist

✍ D. N. Poller; M. Galea; D. Pearson; J. Bell; W. J. Gullick; C. W. Elston; R. W. 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 821 KB

A Phase I/II Trial of Trastuzumab and Ge

✍ Stacy L. Moulder; Carlos L. Arteaga 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB

Mechanisms of ErbB2-mediated paclitaxel

✍ Dihua Yu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 804 KB

Overexpression of ErbB2 receptor inhibit

✍ Yuhong Lu; Xiaolin Zi; Yunhua Zhao; Michael Pollak 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Immunohistochemical expression of c-erbB

✍ NITESH RATNAKAR; BHUVNESH KUMAR SHARMA; K. UMA CHATURVEDI; SUDERSHAN KAUR; S. L. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 920 KB

Overexpression of c-erbB-2 protein and l

✍ O. Stål; C. Klintenberg; S. Sullivan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 730 KB